Submit Your Article CMED MEACR meeting
An official publication of the Middle-Eastern Association for Cancer Research
Clinical Cancer Investigation Journal
ISSN Print: 2278-1668, Online: 2278-0513
ARTICLE
Year: 2019   |   Volume: 8   |   Issue: 3   |   Page: 114-118     View issue

Subcutaneous adipose tissue as a biomarker of pancreatic cancer: A pilot study in male patients


, , , ,
Abstract

Purpose: The purpose of this study was to evaluate the relationship between subcutaneous adipose tissue (SAT) and pancreatic cancer (PC) in male patients. Methods: In this retrospective study, two groups were included. Quantitative assessment of adipose tissue was performed by measuring total adipose tissue (TAT) area, visceral adipose tissue (VAT) area, and the SAT area in both the groups. Then, VAT/SAT ratio was calculated. Results: Statistically significant differences between the two groups were found in the SAT area (P < 0.05), TAT area was slightly above the threshold of significance, while no significant difference was found in the VAT area and VAT/SAT ratio. Conclusions: The results of this study suggest an association between SAT reduction and PC risk.

Cite this article
Vancouver
Greco F, Mallio C, Cirimele V, Grasso R, Zobel B. Subcutaneous adipose tissue as a biomarker of pancreatic cancer: A pilot study in male patients. Clin Cancer Investig J. 2019;8(3):114-8. https://doi.org/10.4103/ccij.ccij_36_19
APA
Greco, F., Mallio, C., Cirimele, V., Grasso, R., & Zobel, B. (2019). Subcutaneous adipose tissue as a biomarker of pancreatic cancer: A pilot study in male patients. Clinical Cancer Investigation Journal, 8(3), 114-118. https://doi.org/10.4103/ccij.ccij_36_19

© Clinical Cancer Investigation Journal
Online since 01 December, 2011
Creative Commons License 
ISSN Print: 2278-1668, Online: 2278-0513